4-Methylumbelliferyl Trimebutine Sulfate(4-Methylumbelliferyl Trimebutine Sulfate)

概要

基本信息

药物类型

小分子化药

别名

4-MUST

靶点-

作用机制-

治疗领域

消化系统疾病

在研适应症

胆囊炎

非在研适应症-

原研机构

Valenta Pharmaceuticals JSC

在研机构

Valenta Pharmaceuticals JSC

非在研机构-

最高研发阶段临床1期

首次获批日期-

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

关联

2

项与 4-Methylumbelliferyl Trimebutine Sulfate 相关的临床试验

NCT06342804 / Recruiting临床1期

An Open-label Crossover Study With 2 Treatments (Fasting and Fed Conditions), 2 Periods, 2 Sequences to Evaluate the Effect of Food Intake on the Bioavailability of 4-MUST, Tablets, 128 mg at a Single Dose of 256 mg in Healthy Volunteers

Primary objective of the study: evaluation of the effect of food intake on the bioavailability of 4-MUST, tablets, 128 mg (Valenta Pharm JSC) after a single oral administration on an empty stomach and after a meal, at a dose of 256 mg (two tablets).
Additional aim of the study: evaluation of pharmacokinetic parameters, safety and tolerability of 4-MUST, tablets, 128 mg (Valenta Pharm JSC) in healthy volunteers after a single oral administration on an empty stomach and after a meal, at a dose of 256 mg (two tablets).

开始日期2024-03-19

申办/合作机构

Valenta Pharmaceuticals JSC

NCT06315387 / Recruiting临床1期

Open Study of Safety, Tolerability and Pharmacokinetic Parameters of Increasing Doses of 4-MUST, Tablets, 128 mg (Valenta Pharm JSC) During Single and Subsequent Multiple Oral Administration in Healthy Volunteers.

Study of safety, tolerability and pharmacokinetic parameters of different doses of 4-MUST, tablets, 128 mg (Valenta Pharm JSC) in healthy volunteers

开始日期2023-12-04

申办/合作机构

Valenta Pharmaceuticals JSC

100 项与 4-Methylumbelliferyl Trimebutine Sulfate 相关的临床结果

登录后查看更多信息

100 项与 4-Methylumbelliferyl Trimebutine Sulfate 相关的转化医学

登录后查看更多信息

100 项与 4-Methylumbelliferyl Trimebutine Sulfate 相关的专利（医药）

登录后查看更多信息

100 项与 4-Methylumbelliferyl Trimebutine Sulfate 相关的药物交易

登录后查看更多信息